In today’s stock market trade, a slew of stocks will be on investors’ radar, including Tata Power, Life Insurance Corporation ...
Updated data show AYVAKIT® (avapritinib) was safe and effective for long-term treatment of ISM, with sustained symptom and quality-of-life bene ...
Cash Burn of $5.2 million in Q4 remains in line with projected $4-5 million quarterly rangeCash and investments on hand are sufficient to fund ...
With the right policies, advanced science, and strong leadership in government agencies, Donald Trump has the power to save ...
Target is slated to unveil its latest plan to jumpstart growth Tuesday, a crucial step in the Minneapolis-based retailer’s ...
M, +43% v. 2023; 4Q 2024 revenues of $77M, +31% v. 4Q 20232024 net income of $28M; Non-GAAP net income of $68M 4Q 2024 net ...
U.S. health agencies will delay by more than two months a decision on updating the definition of the nutrient content claim ...
Florida claims Target intentionally misled shareholders about the true risk of its 2023 Pride campaign, causing investors to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback